For cardioembolic stroke, estimates are more similar amongst the different implementations of the methods, with stronger evidence for MCP‐1 as the causal risk factor at this locus, particularly from the MV‐IVW‐PCA method. This evidence concerns the gene CCL2 and cardioembolic stroke.